DFPR-PRESCRIPTION MONITORING House SponsorsRep. Michael J. Zalewski 1/13/2021HouseSession Sine Die 720 ILCS 570/102from Ch. 56 1/2, par. 1102720 ILCS 570/203from Ch. 56 1/2, par. 1203720 ILCS 570/205from Ch. 56 1/2, par. 1205720 ILCS 570/207from Ch. 56 1/2, par. 1207720 ILCS 570/209from Ch. 56 1/2, par. 1209720 ILCS 570/211from Ch. 56 1/2, par. 1211720 ILCS 570/316720 ILCS 570/317720 ILCS 570/318720 ILCS 570/320720 ILCS 570/507.2 Amends the Illinois Controlled Substances Act. Provides that the Department of Financial and Professional Regulation (instead of the Department of Human Services) must provide for a Prescription Monitoring Program for Schedule II, III, IV, and V controlled substances. Makes conforming and related changes. Provides that within one year after the effective date of the amendatory Act (instead of within one year of January 1, 2018) the Department of Financial and Professional Regulation (instead of the Department of Human Services) shall adopt rules requiring all Electronic Health Records Systems to interface with the Prescription Monitoring Program application program on or before January 1, 2022 (instead of January 1, 2021) to ensure that all providers have access to specific patient records during the treatment of their patients. Contains provisions concerning the transfer of rulemaking authority to the Department of Financial and Professional Regulation from the Department of Human Services. Effective immediately. 5/22/2020HouseFiled with the Clerk by Rep. Michael J. Zalewski 5/22/2020HouseFirst Reading 5/22/2020HouseReferred to Rules Committee 1/13/2021HouseSession Sine Die